Eli Lilly & Co. agreed to buy gene-editing biotech company Verve Therapeutics Inc. for $1.3 billion, the drugmaker’s latest investment in an experimental medicine that could fuel its long-term ...

Sunday’s Child is a weekly column featuring a child currently in foster care awaiting adoption.

A new experimental GLP-1 drug, in pill form, could transform the weight loss drug boom. Eli Lilly's new experimental pill called orforglipron, helped patients shed weight and control blood sugar ...

Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 diabetes lose an average of nearly 8% of their body weight after 40 weeks ...

The first GLP-1 weight-loss pill is a step closer to hitting the market. Eli Lilly said its experimental pill met its goals in a pivotal study, helping diabetes patients lower blood sugar—and ...

The results bring Eli Lilly's pill orforglipron one step closer to becoming a new, needle-free alternative in the booming weight loss and diabetes market.

Lilly Pulitzer and Disney just teamed up for a new collection that’s as colorful and fun as you’d expect. It includes a crossbody belt bag, rompers, tops, skorts, and a take on a popular Lilly ...

But if the patient has questions about insurance coverage, the status of seeking coverage for their medication, injection training, financial assistance, even just talking through things and ...